Ropes & Gray advised Pfizer on the deal. Pfizer announced its strategic investment in and collaboration with CellCentric, which includes $25 million to help finance further development...
Pfizer’s $25 Million Strategic Investment in CellCentric
Redx Pharma’s Merger with Jounce Therapeutics
Cooley advised Redx Pharma on the deal while Ropes & Gray has advised Jounce Therapeutics, Inc. Redx Pharma, a UK clinical-stage biotechnology company, announced its all share...
In re Pandora Media LLC Copyright Litigation
Cravath represented Word Collections in the case. On October 26, 2022, the U.S. District Court for the Central District of California granted Cravath’s motion to dismiss...
NeoGenomics’ Acquisition of Inivata
Ropes & Gray advised NeoGenomics on the deal. NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services and global oncology contract research services, executed its...
Boston Scientific’s $1.07 Billion Acquisition of Lumenis Surgical Business
Ropes & Gray represented an affiliate of Baring Private Equity Asia in the transaction, while Yigal Arnon & Co. and Latham & Watkins represented Boston Scientific,...